in the news articles ↓

With this latest press release, Vicept Therapeutics is now well and truly out in the public view, and attracting interest from rosacea sufferers. This release of results for Phase I trials of V-101 comes after news that Vicept Therapeutics had secured funding for the development of V-101.

Now that a company name has surfaced we can put the pieces together back to 2007 when Rosacea …

News across the business web sites today a new company obtaining funding for a patent protected alpha-adrenergic receptor based treatment for the redness of rosacea.

Vicept Therapuetics is based in Malvern in Pennsylvania and is a privately held company.
From Fidelity Biosciences Joins $10M Series A for Vicept Therapeutics

“We are delighted by the strong investor interest in this round of financing which will allow us to …

A recent submission to the House of Commons Science and Technology Committee has said that using public money on the highly-diluted remedies of homeopathy could not be justified. The cross-party group said there was no evidence beyond a placebo effect, when a patient gets better because of …

European rosaceans unable to fly right now might temper their frustration with the thought that the subtle atmospheric changes caused by the eruption of Eyjafjallajökull might just be helping their symptoms. The volcanic stuff being spewed into the air is rich in sulphurous materials. Sulphur, of course, is a well established rosacea topical. Now, you may be sure that this is no desperate effort …

An interesting piece in the Australian media recently looking at whether treating patients knowingly with placebo treatments might actually offer some benefits. I have always been fascinated with the whole placebo effect. How exactly can our belief …